L’innovazione Cellply in un articolo sulla rivista Le Scienze

Recent Posts

• Cellply, the first biotech to develop and market an end-to-end single cell potency characterization platform concludes a new internal round of €3.6 million and extends the round to new investors
• CellPly announces acceptance of one abstract at the CICON23 conference
• CellPly announces Emiliano Spagnolo as the new CEO
• Schia Ventures nel capitale di CellPly
• Two million Euro round for Cellply to revolutionize the characterization of cell therapies